COVID-19 WAR, Vaccines Versus Medicines

Bahram Alamdary Badlou

Department of Haematology, BBAdvies and Research Company, Netherlands

Dr. Bahram Alamdary Badlou, Department of Haematology, BBAdvies and Research Company, Netherlands.

Keywords: Hypertension; Diabetes; COVID-19

Abstract

Per definition, vaccines are used as preventive and Medicines as therapeutic drugs to save the life of subjects, however. Against COVID-19 mutants still, there is no standard preventive and/or therapeutic approaches, globally [1-5]. Current research studies focused either on molecular or clinically changes of COVID-19 infection mechanism, trying to discover the cellular immune responses, which did not result in standard protocols, yet (January 2021).
Moreover, the associated Vaccines/Medicinal approaches of contracted patients still remained to be standardized, on the other hand.
Recent medical methodologies (2020) considered as prophylactic and/or military’s view-based managements (herd immunity-views), were considered as rapidly developed novel vaccines with associated treatment programs. The main concerns exist over the possible rise of new novel mutants and inflammatory- allergic reactions, which might bring more aggressiveness than current diffused variants, in the near future. Basic Scientists around the world, are studying (Nano-)Microscopic interactions/ vaccines/ medicines to tackle different kinds of mutated COVID-19, under an ex-vivo and/or in-situ conditions.

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).